🇺🇸 inhaled tobramycin in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Blood Pressure Systolic Abnormal — 1 report (10%)
2. Chills — 1 report (10%)
3. Diarrhoea — 1 report (10%)
4. Drug Reaction With Eosinophilia And Systemic Symptoms — 1 report (10%)
5. Erythema — 1 report (10%)
6. Eye Swelling — 1 report (10%)
7. Hypoaesthesia Oral — 1 report (10%)
8. Hypotension — 1 report (10%)
9. Nephropathy — 1 report (10%)
10. Pruritus — 1 report (10%)

Source database →

Frequently asked questions

Is inhaled tobramycin approved in United States?

inhaled tobramycin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for inhaled tobramycin in United States?

Seattle Children's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.